Additional Titles & Roles
- Assistant Professor of Neurology
Education & Training
- Ph.D.: University of Barcelona, 2015
- M.S.: University of Barcelona, 2008
- B.S.: University of Barcelona, 2007
- B.A.: University of Barcelona, 2007
Major Awards
- ESO WSO 2020 Young Investigator Award, 2020
- CZI Neurodegeneration Community Projects, 2019
- Spanish HIV Fundation (FIPSE) travel award, 2013
- PhD Fellowship from the Catalan Goverenment – FIDGR, 2010
Research Interests
My research interests are focused on using genetics to improve the management and well-being of people that suffer from neurodegenerative diseases. Currently there is a great potential in combining genomics and bioinformatics, especially machine learning. Predictive models can easily be used in clinical settings to improve the management and quality of life of patients. My research is focused on the application novel bioinformatics tools to unique longitudinal datasets to create a predictive models for neurodegenerative diseases. My current research aims to create predictive models for Alzheimer Disease and Parkinson’s disease using cell free RNA and cell free DNA present in the plasma of afected individuals.
Recent Publications
-
Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer’s disease
on behalf of Alzheimer’s Disease Genetics Consortium (ADGC), Dec 2025, In: Genome biology. 26, 1, 210.
-
The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
the Global Parkinson’s Genetics Program (GP2), Dec 2025, In: npj Parkinson’s Disease. 11, 1, 58.
-
The landscape of autosomal-dominant Alzheimer’s disease: global distribution and age of onset
the Dominantly Inherited Alzheimer Network, Jul 1 2025, In: Brain. 148, 7, p. 2429-2440 12 p.
-
Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease
for the DIAN-TU Study Team & For the DIAN-Obs Study Team, Jun 2025, In: Acta Neuropathologica. 149, 1, 57.
-
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer’s disease
Dominantly Inherited Alzheimer Network (DIAN), Jun 1 2025, In: The journal of prevention of Alzheimer’s disease. 12, 6, p. 100133 1 p.